Literature DB >> 7589813

Myogenin's functions do not overlap with those of MyoD or Myf-5 during mouse embryogenesis.

A Rawls1, J H Morris, M Rudnicki, T Braun, H H Arnold, W H Klein, E N Olson.   

Abstract

The four myogenic basic helix-loop-helix proteins, MyoD, myogenin, Myf-5, and MRF4, can each activate skeletal muscle differentiation when introduced into nonmuscle cells. During embryogenesis, each of these genes is expressed in a unique but overlapping pattern in skeletal muscle precursors and their descendants. Gene knockout experiments have shown that MyoD and Myf-5 play seemingly redundant roles in the generation of myoblasts. However, the role of either of these genes during differentiation in vivo has not been determined. In contrast, a myogenin-null mutation blocks differentiation and results in a dramatic decrease in muscle fiber formation, yet the role of myogenin in the generation or maintenance of myoblast populations is not known. Because myogenin possesses the same myogenic activity as MyoD and Myf-5 in vitro and the expression patterns of these three genes overlap in vivo, we sought to determine if myogenin shares certain functions with either MyoD or Myf-5 in vivo. We therefore generated mice with double homozygous null mutations in the genes encoding MyoD and myogenin or Myf-5 and myogenin. These mice showed embryonic and perinatal phenotypes characteristic of the combined defects observed in mice mutant for each gene alone. As shown by histological analysis and expression of muscle-specific genes, the numbers of undifferentiated myoblasts and residual myofibers were comparable between myogenin-mutant homozygotes and the double-mutant homozygotes. Myoblasts isolated from neonates of the combined mutant genotypes underwent myogenesis in tissue culture, indicating that no more than two of the four myogenic factors are required to support muscle differentiation. These results demonstrate that the functions of myogenin do not overlap with those of MyoD or Myf-5 and support the view that myogenin acts in a genetic pathway downstream of MyoD and Myf-5.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7589813     DOI: 10.1006/dbio.1995.0004

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  41 in total

1.  The expression of the myogenic regulatory factors in denervated and normal muscles of different phenotypes.

Authors:  E H Walters; N C Stickland; P T Loughna
Journal:  J Muscle Res Cell Motil       Date:  2000       Impact factor: 2.698

2.  Myogenic microRNA expression requires ATP-dependent chromatin remodeling enzyme function.

Authors:  Chandrashekara Mallappa; Brian T Nasipak; Letitiah Etheridge; Elliot J Androphy; Stephen N Jones; Charles G Sagerström; Yasuyuki Ohkawa; Anthony N Imbalzano
Journal:  Mol Cell Biol       Date:  2010-04-26       Impact factor: 4.272

3.  Proto-oncogene Sno expression, alternative isoforms and immediate early serum response.

Authors:  S Pearson-White; R Crittenden
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

4.  Allelic variation in the porcine MYF5 gene detected by PCR-SSCP.

Authors:  Sajee Kunhareang; Huitong Zhou; Jon G H Hickford
Journal:  Mol Biotechnol       Date:  2008-11-20       Impact factor: 2.695

5.  Differential requirements for myogenic regulatory factors distinguish medial and lateral somitic, cranial and fin muscle fibre populations.

Authors:  Yaniv Hinits; Daniel P S Osborn; Simon M Hughes
Journal:  Development       Date:  2009-02       Impact factor: 6.868

Review 6.  An intrinsic genetic program for autonomous differentiation of muscle cells in the ascidian embryo.

Authors:  N Satoh; I Araki; Y Satou
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

7.  Skeletal myogenesis and Myf5 activation.

Authors:  Tanja Francetic; Qiao Li
Journal:  Transcription       Date:  2011-05

8.  Involvement of transportin 2-mediated HuR import in muscle cell differentiation.

Authors:  Kate van der Giessen; Imed-Eddine Gallouzi
Journal:  Mol Biol Cell       Date:  2007-05-02       Impact factor: 4.138

Review 9.  Synergistic up-regulation of muscle LIM protein expression in C2C12 and NIH3T3 cells by myogenin and MEF2C.

Authors:  Zhen-Xing Ji; Chao Du; Guo-Sheng Wu; Shu-Yan Li; Guo-Shun An; Yu-Xi Yang; Ru Jia; Hong-Ti Jia; Ju-Hua Ni
Journal:  Mol Genet Genomics       Date:  2008-11-06       Impact factor: 3.291

10.  Defective T-cell activation is associated with augmented transforming growth factor Beta sensitivity in mice with mutations in the Sno gene.

Authors:  S Pearson-White; M McDuffie
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.